Polysialylation and disease

Mol Aspects Med. 2021 Jun:79:100892. doi: 10.1016/j.mam.2020.100892. Epub 2020 Aug 27.

Abstract

Polysialic acid (polySia, PSA) is a unique constituent of the glycocalyx on the surface of bacterial and vertebrate cells. In vertebrates, its biosynthesis is highly regulated, not only in quantity and quality, but also in time and location, which allows polySia to be involved in various important biological phenomena. Therefore, impairments in the expression and structure of polySia sometimes relate to diseases, such as schizophrenia, bipolar disorder, and cancer. Some bacteria express polySia as a tool for protecting themselves from the host immune system during invasion. PolySia is proven to be a biosafe material; polySia, as well as polySia-recognizing molecules, are key therapeutic agents. This review first comprehensive outlines the occurrence, features, biosynthesis, and functions of polySia and subsequently focuses on the related diseases.

Keywords: Autism spectrum disorder; BDNF; Bipolar disorder; Brain; Dopamine; Mental disorder; Neural cell adhesion molecule; Neurotrophic factor; Polysialic acid; Polysialyltransferase; ST8SIA2; Schizophrenia; Sialic acid.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Glycocalyx
  • Humans
  • Sialic Acids*
  • Sialyltransferases / genetics

Substances

  • Sialic Acids
  • polysialic acid
  • Sialyltransferases